This meeting considered a number of aspects of the importance oflipids in the development of cancer, the day beginning with a lecture by Dr M J Hill of Porton Down, who reviewed the evidence concerning the involvement of dietary lipids in the uneven incidence of cancer throughout the world. Strong positive correlations exist between the total dietary fat intake and the mortality from major cancer such as colon, breast, endometrial, ovarian and prostate cancers, reflecting the higher incidence of all of these in the industrialized world where fat consumption is high. By contrast, the incidence of stomach cancer is inversely correlated with dietary fat, again reflecting the higher incidence of this cancer in less affluent countries. In other studies a protective effect of green leafy vegetables was demonstrated particularly for colon cancer.
Correlation does not prove causality, and the question of how fats may help induce cancers is far more difficult. Ideas on this are more advanced in the case of colon cancers, where a role for secondary faecal bile acids (FBA) as adenoma activators has been proposed. Dietary fats increase the output of FBA. In the case of breast cancer the association is more difficult, but a higher incidence may be related to earlier menarche. latet menopause, increased body weight related to a greater energy intake and therefore greater breast adiposity. This may lead to a concomitant rise in the density of oestrogen receptors in the cells.
The inverse relationship of dietary fat in stomach cancer is interesting. In Japan it has been estimated that a glass of milk per day may halve the risk of developing stomach cancer. The proposal is that low fat intake is often associated with a poorer level of nutrition which may lead to the early appearance of achlorhydria. This would permit abnormal bacterial growth and the production of nitrosamines in the stomach, leading to the development of cancer after 20 years or more. Achlorhydria is more common among the elderly population in industrialized countries, but there is less time for the cancer to develop. There is some evidence that this cancer is more prevalent among vegetarians. although the incidence of bowel cancer is lower.
Professor T F Slater of BruneI University discussed the importance of the peroxidation of fats in the development of cancer. The tendency for these lipids to undergo peroxidation is part of a permanent process in normal tissue in which free radicals are generated as a normal part of cellular activity which, if unchecked, would cause considerable damage to the cells. Tissues normally have a number of proteetive enzymes which inhibit lipid peroxidation, e.g. superoxide dismutase, catalase and glutathione dismutase. There are also present a number of naturally occurring antioxidants such as a-tocopherol, ascorbate and glutathione, which also slow these processes and act as breakers in the chain reactions that propagate peroxidation. Many liver tumours have reduced levels of lipid peroxidation compared with that of normal liver. This property can be ascribed to the higher levels of antioxidants present in these tumours, particularly a-tocopherol. This accumulation seems to be associated with rapid cell growth, since a similar phenomenon has been observed in regenerating liver. Lipid peroxidation may have a strong inhibiting effect on DNA synthesis. and this may be overcome in tumour cells by the presence of antioxidants. However, the formation of free radicals may also be important in the initiation and promotion of tumours.
Another section of the meeting related to a dis. cussion of the importance of lipids or lipophilicity in cancer therapy and tumour detection. Dr D Kerr, of the CRC Glasgow, explained the increasing interest in the synthesis of lipophilic analogues of established anticancer agents. This arises because of the recognition that cytotoxic drug resistance may occur, in part, from a decreased penetration of the drugs. This resistance is commonly effected by changes in membrane permeability to the drugs. Compounds with a greater oil/water partition coefficient are more likely to overcome this problem. Furthermore, lipophilic analogues display a much better penetration of ball tumours where ordinary drugs are only effective for the outer three or four layers of cells. This was demonstrated effectively using a human lung tumour multicellular spheroid model.
Another approach to drug therapy, described by Dr G Gregoriadis of the Royal Free Hospital, is the encapsulation of antitumour agents in liposomes. Liposomes are essentially spherical artificial membranes made from lipid mixtures. The composition of the lipids is important; stable liposomes are less likely to be removed from the circulation prematurely by the reticuloendothelial system. Greater stability is conferred by a high content ofsphingomyelin and of cholesterol. The effectiveness of a strategy of liposome encapsulation is attributed to (1) the access of small Iiposcmes to the tumour mass, the mechanism being uncertain; (2) the slow release of drugs in the circulation; and (3) drugs. Liposomes also have an important immunoadjuvant activity. They can, therefore, be employed carrying cell-surface tumour antigens to induce antitumour responses.
The application of liposomes to antitumour treatment is now made more practicable by the introduction of simple and mild procedures for the preparation of liposomes and the incorporation of drugs within them. Also it is now possible to prepare targeted liposomes by the covalent coupling of cellspecific ligands.
There is some potential for the use of liposomes in tumour detection as well as for therapy. Dr R H J Begent of Charing Cross Hospital described how liposome entrapped second antibodies (LESA) are directed against the first antitumour antibody which is not tumour bound. LESA are then cleared by the reticuloendothelial system. This LESA-accelerated clearance of radiolabelled first antibody (carcinoembryonic antigen) has been shown to enhance the gamma-camera imaging in patients with gastrointestinal cancer.
Finally, the meeting dealt with the question of the association between lipoproteins and cancer. Epidemiological studies on the incidence of cancer in inter-country populations show an association between high serum cholesterol concentrations and a high incidence of cancer. However, studies within defined populations show a relationship between hypocholesterolaernia and cancer risk. The causeeffect relationship is not clear. In some leukaemic patients it appears that the hypocholesterolaemia is associated with an increase in low-density lipo-protein (LDL) receptors, LDL uptake and degradation by leukaemic cells.
This kind of relationship has also been found by Dr C Peterson of the Karolinska Institute, Stockholm, for crude homogenates of breast cancer tissue. There was an inverse relationship between LDL receptor concentration and prediction of survival after surgery, especially if this information was used with other prognostic data.
The possibility is being explored by both Dr Peterson and Dr J Shepherd (Royal Infirmary, Glasgow) that LDL may be used as carrier for lipophilic antitumour drugs. LDL may be taken up by specific receptors and is not susceptible to the resistance mechanisms and allergic responses observed with other systems. On the other hand, LDL uptake does not show a high degree of organ specificity, so it may be necessary to suppress its uptake by gonadal tissues with hydrocortisone. Experiments with animal models show some promise, but more work needs to be done.
The meeting therefore covered many aspects of lipids in relation to tumours. Clearly this is an area capable of greater development and the meeting looked forward to hearing of more progress in the ensuing years. However, more complex problems in every sense were posed, he said, by the very premature.
K R Bruckdorfer
Perinatal mortality declined greatly between 1931 and 1976. It declined again between 1976 and 1984 despite increased economic constraints on hospital services during this period. Dr Harvey showed a slide of what he described as the classic picture of a tiny baby rendered almost invisible by the technological machinery surrounding it, but pointed out that such machines appeared to be less crucial for many babies' survival than the quality of medical and nursing care.
Since 1978, the survival rate for babies born at over 30 weeks' gestation has been near 100%. In that year the rate for babies born at 28 weeks was 50%; this 50% mark has now descended to 25 weeks and a few have survived at the age of23 weeks, but none below that. Quoting figures differently expressed, from a survey in Avon, Dr Harvey pointed out that the fact that between 1976 and 1980 the 'live' births of babies weighing under 1000g had apparently increased fourfold meant, essentially, that many more of these babies were now regarded as salvageable than had been the case formerly. A survey from the Australian state of Victoria, carried out in specialized centres for the premature in the period 1979-80, indicated that 29% of the under 1000g babies were surviving, while the rate was only 17% for ordinary hospitals. This was in spite of the fact that the specialized centres tended to get the most problematic babies; their rate of producing handicap-free babies was also better.
This, Dr Harvey indicated, was the heart of the problem: tiny babies are very easily damaged -even by procedures that would not damage a larger infant. Brain haemorrhages are common in the very premature; these can lead to profound deafness or mental handicap. There is also a risk of cysts developing. This is why, as late as the immediate post-War period, most premature babies either died or grew up handicapped. Today the numbers of those who survive and
